Food and Drug Administration, HHS § 329.1 section 502(e) of the Federal Food, PART 329ÐHABIT-FORMING DRUGS Drug, and Cosmetic Act. (d) The statement expressing the Subpart AÐDerivatives Designated as amount (percentage) of alcohol present Habit Forming in the product shall be in a size reason- ably related to the most prominent Sec. printed matter on the panel or label on 329.1 Habit-forming drugs which are chem- which it appears, and shall be in lines ical derivatives of substances specified in generally parallel to the base on which section 502(d) of the Federal Food, Drug, the package rests as it is designed to be and Cosmetic Act. displayed. (e) For a product to state in its label- Subpart BÐLabeling ing that it is ``alcohol free,'' it must 329.10 Labeling requirements for habit- contain no alcohol (0 percent). forming drugs. (f) For any OTC drug product in- tended for oral ingestion containing Subpart CÐExemptions over 5 percent alcohol and labeled for use by adults and children 12 years of 329.20 Exemption of certain habit-forming age and over, the labeling shall contain drugs from prescription requirements. the following statement in the direc- AUTHORITY: 21 U.S.C. 352, 353, 355, 371. tions section: ``Consult a physician for use in children under 12 years of age.'' SOURCE: 39 FR 11736, Mar. 29, 1974, unless (g) For any OTC drug product in- otherwise noted. tended for oral ingestion containing over 0.5 percent alcohol and labeled for Subpart AÐDerivatives use by children ages 6 to under 12 years Designated as Habit Forming of age, the labeling shall contain the following statement in the directions § 329.1 Habit-forming drugs which are section: ``Consult a physician for use in chemical derivatives of substances children under 6 years of age.'' specified in section 502(d) of the (h) When the direction regarding age Federal Food, Drug, and Cosmetic in paragraph (e) or (f) of this section Act. differs from an age-limiting direction Each of the following chemical de- contained in any OTC drug monograph rivatives of a substance named in sec- in this chapter, the direction con- tion 502(d) of the Federal Food, Drug, taining the more stringent age limita- and Cosmetic Act is hereby designated tion shall be used. as habit forming: Chemical description of derivative Common or official name of chemical Some trade or other names of chem- derivative or its salts ical derivative or its salts 1 PARENT SUBSTANCEÐBARBITURIC ACID 5-Allyl-5-sec-butylbarbituric acid 2 ...................... Talbutal ............................................... Lotusate. 5-Allyl-5-cyclopentenylbarbituric acid ................. ............................................................. Cyclopal. Cyclopen. 5-Allyl-5-isobutylbarbituric acid ........................... Allylbarbituric acid ............................... Sandoptal. Allylisobutylbarbituric acid.. 5-Allyl-5-isopropylbarbituric acid ........................ Aprobarbital ......................................... Alurate. Allylisopropylbarbituric acid ................. Numal. Allylisopropylmalonylurea.. 5-Allyl-5-isopropyl-1-methylbarbituric acid ......... ............................................................. Narconumal. 5-Allyl-5-(1-methylbutyl)barbituric acid ............... Secobarbital sodium ........................... Seconal Sodium. Soluble secobarbital ............................ Evronal Sodium. 5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid ..... Sodium thiamylal ................................. Surital Sodium. 5-Allyl-1-methyl-5-(1-methyl-2-pentynyl) barbi- Sodium methohexital .......................... Brevital Sodium. turic acid. 5-(2-Bromoallyl)-5-isoprophyl-1-methylbarbituric ............................................................. Eunarcon. acid. 5-(2-Bromoallyl)-5-(1-methylbutyl)-barbituric β-Bromoallyl sec-amylbarbituric acid .. Sigmodal. acid. Rectidon. R239. 5-sec-Butyl-5-(2-bromoallyl)-barbituric acid ....... Butallylonal .......................................... Pernoston. Pernocton. 5-(1-Cyclohepten-1-yl)-5-ethylbarbituric acid ..... Heptabarbital ....................................... Medomin. 201 VerDate 18<APR>2000 13:58 Apr 20, 2000 Jkt 190065 PO 00000 Frm 00201 Fmt 8010 Sfmt 8010 Y:\SGML\190065T.XXX pfrm02 PsN: 190065T.